Stemtech Corporation(STEK.US)

Stemtech Corp. Names Dr. Lizette Leos as Chief Scientific Officer

Stemtech Corporation has appointed Dr. Lizette Leos, MD, as Chief Scientific Officer. Dr. Leos will oversee global scientific validation and support Stemtech’s initiatives in India, the Gulf Cooperation Council countries, and Asia. She has been with the company since 2017, contributing to the development of its plant-based nutritional supplements.

Stemtech Corp. Forms Joint Venture With Lightway Ventures to Enter China Market

Stemtech Corp. has formed a joint venture with Lightway Ventures to enter the China market, establishing Stemtech Asia (Hong Kong) for distributing stem cell nutrition products. Stemtech holds a 51% stake, Lightway Ventures 49%, with profits split equally. The venture targets major e-commerce and pharmacy channels, planning local manufacturing and initial rollout in Shanghai and Beijing, pending funding and regulatory approvals.

Stemtech Corporation | 10-Q: FY2025 Q3 Revenue: USD 852.3 K

Stemtech Corp. Delays Quarterly Financial Report Filing

Stemtech Corporation announced a delay in filing its quarterly report on Form 10-Q for the period ended September 30, 2025, due to delays in preparing its financial statements. The company expects to file within the allowed extension period.

Stemtech Corp. Launches Joint Venture With Innoventure Dynamic LLP in India

Stemtech Corporation has launched a joint venture with Innoventure Dynamic LLP in India, forming STEMTECH HEALTHSCIENCES INDIA PRIVATE LIMITED. Stemtech holds 51% ownership while Innoventure holds 49%. The partnership aims to introduce Stemtech’s stemceutical products in India, with plans for rapid expansion and local manufacturing. Additionally, the venture will explore growth opportunities in GCC countries, utilizing Innoventure's distribution network.